Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

5.64
Delayed Data
As of Feb 05
 -0.12 / -2.08%
Today’s Change
4.71
Today|||52-Week Range
10.44
-30.46%
Year-to-Date
No recent news for Cardiome Pharma Corp.

Today’s Trading

Previous close5.76
Today’s open5.69
Day’s range5.45 - 5.69
Volume11,928
Average volume (3 months)35,953
Market cap$111.1M
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-402.70%
Earnings growth (this year)-2.46%
Earnings growth (next 5 years)--
Revenue growth (last year)+565.97%
P/E ratio--
Price/Sales4.98
Price/Book5.46

Competitors

 Today’s
change
Today’s
% change
AMPEAmpio Pharmaceutical...-0.18-7.89%
MDGNMedgenics Inc-0.17-4.87%
RDHLRedhill Biopharma Lt...-0.13-1.50%
GALEGalena Biopharma Inc-0.03-4.58%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$30.0M
Annual profit (last year)-$18.2M
Net profit margin-60.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William L. Hunter
Chief Operating Officer
Sheila M. Grant
Corporate headquarters
Vancouver, British Columbia

Forecasts

Partner Offers